Ledger.Open graph →
SEC Form D · filed July 14, 2017

Akoya Biosciences, Inc

Offering
$9.0M
Sold
$9.0M
Exemption
Rule 506(b)
Industry
Other
Location
SAN FRANCISCO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Dapeng Xu · New York, NYExecEric J. Kramer · BOULDER, CODirectorGarry Nolan · Richmond Hill, Ontario, CanadaDirectorRobert Shepler · Shavano Park, TXDirectorMatthew Winkler · West Lake Hills, TXDirectorBrian Mckelligon · San Francisco, CAExecGarth Ebanks · Grand Cayman, Cayman IslandsExecPatrick B. Horsman · Scottsdale, AZDirectorGarry Nolan · Menlo Park, CADirectorRobert Shepler · Seattle, WADirectorMatthew Winkler · Austin, TXDirectorBrian Mckelligon · Menlo Park, CAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗